Concomitant low dose-rate irradiation and cis platin treatment in ovarian carcinoma cell lines sensitive and resistant to cis platin treatment

References

• BEGG, A. C., 1990, Cisplatin and radiation: interaction prob-abilities and therapeutic possibilities.InternationalJournal of Radiation Oncology, 19, 1183–1189.
   PubMed Web of Science ®Google Scholar
• BEGG, A. C., VAN DER KOLL P. L., DEWIT and BARTELINK, H., 1986, Radiosensitization by cisplatin of RIF1 tumour cells in vitro. InternationalJournal of Radiation Oncology, 50, 871–884.
   Google Scholar
• BRITTEN, R. A., WARENIUS, H. M., CARRAWAY, A. V. AND MURRAY D., 1994, Differential modulation of radiosensitivity fol-lowing induction of cisplatin resistance in radiation-sensitive and radiation-resistant human cells. Radiation Oncology Investigations, 2, 25–31.
   Google Scholar
• GARDE, P. and LAVAL, F., 1981, Effect of cis-dichlorodiamine platinum II and X-rays on mammalian cell survival. International Journal of Radiation Oncology, 7,929–933.
   Web of Science ®Google Scholar
• COUGHLIN, C. T. and RICHMOND, R. C., 1985, Platinum based combined modality approach for locally advanced head and neck carcinoma. International Journal of Radiation Oncology, 115, 915–919.
   Google Scholar
• DA SILVA, V., GCTIN, P. H. HoFF, M. H. B., BERNSTEIN, M. A., DEEN, D. F. and WEAVER, K. A., 1984, The effect of combina-tion treatment with cisplatin and low dose rate 125 I radiation in a murine brachytherapy model. Interna-tional Journal of Radiation Oncology, 10, 1271–1472
   Google Scholar
• DEWIT, L., 1987, Combined treatment of radiation and cis-diaminedichloroplatinum (II): a review of experimen-tal and clinical data. International Journal of Radiation Oncology, 13, 403–426.
   Web of Science ®Google Scholar
• DEWIT, L., BARTELINK, H. and RUMKE, P. H., 1985, Concurrent cis-diamminedichloroplatinum (II) and radiation treat-ment for melanoma metastases: a pilot study. Radio-therapy and Oncology, 3, 303–309.
   PubMed Web of Science ®Google Scholar
• DOCPLE, E. B., 1990, Antitumour drug-radiation interactions, Interaction between cisplatin coordination complexes and radiation, edited by B. T. Hill and A. S. Bellamy (Boca Raton: CRC Press), pp. 171–190.
   Google Scholar
• DouPLE, E. B., WILLS, M. L. and JONES, E., 1991, Concomitant Continuous Infusion Chemotherapy and Radiation (New York: Springer) pp. 191–196.
   Google Scholar
• DRITSCHILO, A., PIRO, A. and KELMAN, A. D., 1979, The effect of cisplatinum on the repair of radiation damage in plateau phase Chinese hamster V79 cells. International Journal of Radiation Oncology,5, 1345–1349
   Web of Science ®Google Scholar
• DouPLE, E. B. and RICHMOND, R. C., 1979, Radiosensitization of hypoxic tumour cells by cis-and trans-dichlordiammen-platium (II). International Journal of Radiation Oncology, Biology, Physics, 5, 1369–1372.
   PubMed Web of Science ®Google Scholar
• Fu, K. K., RAYNER, P. A. and LAM K. N., 1984, Modification of the effects of continuous low dose rate irradiation by concurrent chemotherapy infusion. International Jour-nal of Radiation Oncology, 10, 1431–1478.
   Google Scholar
• Fu, K. K., LAM K. N. and RAYNER, P. A., 1985, The influence of time sequence of cisplatin administration and contin-uous low dose rate irradiation (LDRI) on their com-bined effects on murine squamous cell carcinoma. InternationalJournal of Radiation Oncology, 11, 2119–2124.
   Google Scholar
• Fu, K. K, LAM, K. N. and RAYNER, P. A., 1986, Effects of continuous low dose rate irradiation and concurrent infusion of mitomycin, cisplatin and 5 Flourouracil on three murine tumours. Endocurietherapy/Hyperthermia Oncology, 2, 157–162.
   Google Scholar
• HAMILTON, T.C., LAI, G. M., ROTHENBERG, L. M., Foy), A. T., YOUNG, R. C. and OzoLs, R. F. 1989, Drug Resistance in Cancer Therapy, Mechanisms of Resistance to Cisplatin and A lkyla ting Agents, (Boston:Kluwer), edited by R,F, OzoLs pp. 151–169.
   Google Scholar
• HASELOW, R. E., ADAMS, G. S., OKEN, M. M., GOUDSMET, A., LERME, H. J. and MARSH, IC., 1982, Simultaneous cisplatin (DDP) and radiation therapy for locally advance unresectable head and neck cancer. Interna-tional Journal of Radiation Oncology, Biology, Physics, 8,201.
   Google Scholar
• KEIZER, H. J., KARIM, A. B.M. F., NJo, K. H., TIERIE, A. H., SNOW, G. B., VERMORKEN, J. B. and PINED°, H. M., 1984, Feasibility study on daily administration of cis-diammi-nedichloroplatinum(H) in combination with radio-therapy. Radiotherapy and Oncology, 1, 227–234.
   Google Scholar
• KORBELIK, M. and Siov, K. A., 1989, Interaction of hypoxic cells by cisplatin and radiation at clinically relevant doses. Radiation Research, 119,145–156.
   PubMed Web of Science ®Google Scholar
• KUSKE, R. R., PEREZ, C. A., GRIGSBY, P. W., LOVETT, R. D., JAcoas, A. J., GALAKAT05, A. E., CAMEL, H. M. and KA0, M. S., 1989, Phase I/II study of definitive radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) for advanced or recurrent gynecologic malignancies. Amer-ican Journal of Clinical Oncology, 12, 467–473.
   Google Scholar
• LAI, G. M., OzoLs, R. F., SmYrH, J. F., YOUNG, R. C. and HAMILTON, T. C., 1988, Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. Biochemical Pharmacology, 37, 4597–4600.
   PubMed Web of Science ®Google Scholar
• NIAS, A. H. W., 1985 Radiation and platinum drug interaction. International Journal of Radiation Biology, 48, 297–314.
   Web of Science ®Google Scholar
• OSHITA, F., FUJIWARA, Y, and SAIjo, N., 1992, Radiation sen-sitivities in various anticancer drug-resistant human lung cancer cell lines and mechanism of radiation cross-resistance in a cisplatin-resistant cell line. Journal of Cancer Research and Clinical Oncology, 119, 28–34.
   PubMed Web of Science ®Google Scholar
• PIVER, M. S., 1984, OVARIAN CARCINOMA, A DECADE OF PROGRESS. Cancer, 54, 2706–2715.
   PubMedGoogle Scholar
• POP, L., LOVENDAY, P., VAN GEEL, C., DEURLOO, I. K. and VISSER, A., 1992, Lack of therapeutic gain when low dose rate interstitial radiotherapy is combined with cisplatin in an animal tumour model. European Journal of Cancer, 28, 1471–1474.
   Google Scholar
• RAAPHORST, G. P., FEELEY, M. M. DANJOUX, C. E., DA SILVA, V. and GERIGNRM, L. H., 1991, Hyperthermia enhancement of radiation response and inhibition of recovery from radiation damage in human glioma cells. International Journal of Hyperthermia, 7,629–641.
   PubMed Web of Science ®Google Scholar
• RAAPHORST, G. P., MAO, J. P. and NG, C. E., 1993, Repair of potentially lethal damage: its inhibition by hyperther-mia in two melanoma cell lines with different radio-and heat sensitivities. Melanoma Research, 3, 351–356.
   PubMed Web of Science ®Google Scholar
• RAAPHORST, G. P., WANG, G. and NG, E., 1995, Radiosensitiza-tion by cisplatin treatment in cisplatin resistant and sensitive human ovarian carcinoma cell lines. Interna-tional Journal of Oncology, 7,325–330.
   PubMed Web of Science ®Google Scholar
• SCANLON, K. J., KASHANI-SABET, M., TONE, T. and FUNATO, T., 1991,Cisplatin resistance in human cancers. Pharmaco-logical Therapy, 52, 385–406.
   Google Scholar
• SCHWACHOFER, J. H. M., CROOHMANS, R. P. M. A., HOOGENHOUT, J., KAL, H. B. and THEEUWES, A. G. M., 1991, Effective-ness in inhibition of recovery of cell survival by cisplatin and carboplatin influence of treatment sequence. International Journal of Radiation Oncology, 20, 1235–1241.
   Google Scholar
• SKOV, K. and MACPHAIL, S., 1991, Interaction of platinum drugs by clinically relevant x-ray doses in ammalian cells: a comparison of cisplatin, carboplatin,irroplatin and tetraplatin.. International Journal of Radiation Oncology, Biology, Physics, 20, 221–225
   PubMed Web of Science ®Google Scholar
• SLEDGE, G. W., 1992, Cisplatin and platinum analogues in breast cancer. Seminars in Oncology, 19, 78–82.
   PubMedGoogle Scholar
• SZUMIEL, I. and NIAS, A. H. W., 1976, The effect of combined treatment with a platinum complex and ionizing radiation of Chinese hamster ovary cells in vitro. British Journal of Cancer, 33, 450–458.
   PubMed Web of Science ®Google Scholar
• WALLNER, K. E. and LI G. C., 1987, Effect of cisplatin resistance on cellular radiation response. International Journal of Radiation Oncology, 13, 587–591.
   Google Scholar
• WALTEr, P., KORBELIK, M., SPADINGER, I. and SKOV, K., 1993, Investigations into mechanisms of the interaction between platinum complexes and irradiation at low (2 Gy) doses in hypoxic cells: role of single strand breaks. Radiation Oncology Investigations, 1, 137–147.
   Google Scholar
• WILKINs, D. E., NG, C. E. and RAAPHORST, G. P., 1995, Cisplatin and low dose rate irradiation in cisplatin resistant and sensitive human glioma cells. International Journal of Radiation Oncology (submitted).
   Google Scholar
• WILKINS, D. E., RAAPHORST, G. P. and HELLER, D.P.,1993, Inhibi-tion of potentially lethal damage recovery by cisplatin in the 9L rat brain cell line. Anti Cancer Research, 13, 2137–2142.
   Google Scholar